RNA interference and its application in bone-related diseases

Biochemical and Biophysical Research Communications

Volumn 361, Issue 4, 2007, Pages 817-821

  Li, Ya Lin ^a   Quarles, L Darryl ^b   Zhou, Hong Hao ^a   Xiao, Zhou Sheng ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Bone related disease; Gene silencing; RNA interference; Small hairpin RNA; Small interfering RNA; Therapy

Indexed keywords

MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

BONE DISEASE; EWING SARCOMA; GENE DELIVERY SYSTEM; GENE FUNCTION; HUMAN; NONHUMAN; OSTEOARTHRITIS; OSTEOSARCOMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RNA DEGRADATION; RNA INTERFERENCE; SHORT SURVEY;

BONE DISEASES; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 34547900729     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.123     Document Type: Short Survey

References (67)

1. Almeida R., and Allshire R.C. RNA silencing and genome regulation. Trends Cell. Biol. 15 (2005) 251-258
2. Napoli C., Lemieux C., and Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant. Cell. 2 (1990) 279-289
3. Fulci V., and Macino G. Quelling: post-transcriptional gene silencing guided by small RNAs in Neurospora crassa. Curr. Opin. Microbiol. 10 (2007) 199-203
4. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
5. Montgomery M.K., Xu S., and Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 95 (1998) 15502-15507
6. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., and Kay M.A. RNA interference in adult mice. Nature 418 (2002) 38-39
7. Kittler R., and Buchholz F. RNA interference: gene silencing in the fast lane. Semin. Cancer. Biol. 13 (2003) 259-265
8. Bagasra O., and Prilliman K.R. RNA interference: the molecular immune system. J. Mol. Histol. 35 (2004) 545-553
9. Zamore P.D., Tuschl T., Sharp P.A., and Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21-23 nucleotide intervals. Cell 101 (2000) 25-33
10. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
11. Knight S.W., and Bass B.L. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 293 (2001) 2269-2271
12. Bernstein E., Caudy A.A., Hammond S.M., and Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (2001) 295-296
13. Miyagishi M., and Taira K. Development and application of siRNA expression vector. Nucleic Acids Res. Suppl. 2 (2002) 113-114
14. Sui G., and Shi Y. Gene silencing by a DNA vector-based RNAi technology. Methods Mol. Biol. 309 (2005) 205-218
15. Davidson B.L., and Harper S.Q. Viral delivery of recombinant short hairpin RNAs. Methods Enzymol. 392 (2005) 145-173
16. Chen W., Liu M., Jiao Y., Yan W., Wei X., Chen J., et al. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo. J. Virol. 80 (2006) 3559-3566
17. Teusner J.T., Lewin A.S., and Hauswirth W.W. Down-regulation of rhodopsin gene expression by AAV-vectored short interfering RNA. Adv. Exp. Med. Biol. 572 (2006) 233-238
18. Barton G.M., and Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. USA 99 (2002) 14943-14945
19. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
20. Wiznerowicz M., and Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77 (2003) 8957-8961
21. Piersanti S., Sacchetti B., Funari A., Di Cesare S., Bonci D., Cherubini G., et al. Lentiviral transduction of human postnatal skeletal (stromal, mesenchymal) stem cells: in vivo transplantation and gene silencing. Calcif. Tissue Int. 78 (2006) 372-384
22. Zwicky R., Muntener K., Goldring M.B., and Baici A. Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes. Biochem. J. 367 (2002) 209-217
23. Zhong N., Gersch R.P., and Hadjiargyrou M. Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone 39 (2006) 5-16
24. Anderson P.H., Atkins G.J., Findlay D.M., Oloughlin P.D., Welldon K., Vincent C., et al. 25 (OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. J. Steroid. Biochem. Mol. Biol. 103 (2007) 601-605
25. Kovar H., Ban J., and Pospisilova S. Potentials for RNAi in sarcoma research and therapy: Ewing's sarcoma as a model. Semin. Cancer Biol. 13 (2003) 275-281
26. Owen L.A., and Lessnick S.L. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma. Cell Cycle 5 (2006) 2049-2053
27. Lin L., Chen L., Wang H., Wei X., Fu X., Zhang J., et al. Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model. Biochem. Biophys. Res. Commun. 349 (2006) 564-572
28. Tomita T., Takeuchi E., Tomita N., Morishita R., Kaneko M., Yamamoto K., et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 42 (1999) 2532-2542
29. Roman-Blas J.A., and Jimenez S.A. NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14 (2006) 839-848
30. Schiffelers R.M., Xu J., Storm G., Woodle M.C., and Scaria P.V. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum. 52 (2005) 1314-1318
31. Huber L.C., Distler O., Gay R.E., and Gay S. Antisense strategies in degenerative joint diseases: sense or nonsense?. Adv. Drug Deliv. Rev. 58 (2006) 285-299
32. Matsumoto S., Miyagishi M., and Taira K. Genome-wide screening by using small-interfering RNA expression libraries. Methods Mol. Biol. 360 (2007) 131-142
33. Barik S. Silence of the transcripts: RNA interference in medicine. J. Mol. Med. 83 (2005) 764-773
34. Lee S.H., and Sinko P.J. siRNA-getting the message out. Eur. J. Pharm. Sci. 27 (2006) 401-410
35. Salgado P.S., Koivunen M.R., Makeyev E.V., Bamford D.H., Stuart D.I., and Grimes J.M. The structure of an RNAi polymerase links RNA silencing and transcription. PLoS. Biol. 4 (2006) e434
36. Rossi J.J. Mammalian Dicer finds a partner. EMBO Rep. 6 (2005) 927-929
37. Gatignol A., Laine S., and Clerzius G. Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity?. Retrovirology 27 (2005) 65
38. Mathieu O., and Bender J. RNA-directed DNA methylation. J. Cell. Sci. 117 (2004) 4881-4888
39. Lippman Z., and Martienssen R. The role of RNA interference in heterochromatic silencing. Nature 431 (2004) 364-370
40. Stevenson D.S., and Jarvis P. Chromatin silencing: RNA in the driving seat. Curr. Biol. 13 (2003) R13-R15
41. Ichim T.E., Li M., Qian H., Popov I.A., Rycerz K., Zheng X., et al. RNA interference: a potent tool for gene-specific therapeutics. Am. J. Transplant. 4 (2004) 1227-1236
42. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
43. Santoyo J., Vaquerizas J.M., and Dopazo J. Highly specific and accurate selection of siRNAs for high-throughput functional assays. Bioinformatics 21 (2005) 1376-1382
44. Tsuda N., Kawano K., Efferson C.L., and Ioannides C.G. Synthetic microRNA and double-stranded RNA targeting the 3′-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells. Int. J. Oncol. 27 (2005) 1299-1306
45. Wang L., and Mu F.Y. A Web-based design center for vector-based siRNA and siRNA cassette. Bioinformatics 20 (2004) 1818-1820
46. Martin S.E., Jones T.L., Thomas C.L., Lorenzi P.L., Nguyen D.A., Runfola T., et al. Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res. 35 (2007) e57
47. Miyagishi M., Sumimoto H., Miyoshi H., Kawakami Y., and Taira K. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells. J. Gene. Med. 6 (2004) 715-723
48. Miyagishi M., and Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20 (2002) 497-500
49. Boutla A., Delidakis C., Livadaras I., and Tabler M. Variations of the 3′ protruding ends in synthetic short interfering RNA (siRNA) tested by microinjection in Drosophila embryos. Oligonucleotides 13 (2003) 295-301
50. Haeberli P., Berger I., Pallan P.S., and Egli M. Syntheses of 4′-thioribonucleosides and thermodynamic stability and crystal structure of RNA oligomers with incorporated 4′-thiocytosine. Nucleic Acids Res. 33 (2005) 3965-3975
51. Grunweller A., Wyszko E., Bieber B., Jahnel R., Erdmann V.A., and Kurreck J. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31 (2003) 3185-3193
52. Boden D., Pusch O., Silbermann R., Lee F., Tucker L., and Ramratnam B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res. 32 (2004) 1154-1158
53. Prakash T.P., Allerson C.R., Dande P., Vickers T.A., Sioufi N., Jarres R., et al. Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J. Med. Chem. 48 (2005) 4247-4253
54. Spagnou S., Miller A.D., and Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43 (2004) 13348-13356
55. Wu M.T., Wu R.H., Hung C.F., Cheng T.L., Tsai W.H., and Chang W.T. Simple and efficient DNA vector-based RNAi systems in mammalian cells. Biochem. Biophys. Res. Commun. 330 (2005) 53-59
56. Fish R.J., and Kruithof E.K. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol. Biol. 3 (2004) 9
57. Hamilton D.L., and Abremski K. Site-specific recombination by the bacteriophage P1 lox-Cre system. Cre-mediated synapsis of two lox sites. J. Mol. Biol. 178 (1984) 481-486
58. Fritsch L., Martinez L.A., Sekhri R., Naguibneva I., Gerard M., Vandromme M., et al. Conditional gene knock-down by CRE-dependent short interfering RNAs. EMBO Rep. 5 (2004) 178-182
59. Tiscornia G., Tergaonkar V., Galimi F., and Verma IM. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101 (2004) 7347-7351
60. Coumoul X., Li W., Wang R.H., and Deng C. Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res. 32 (2004) e85
61. Coumoul X., and Deng C.X. Roles of FGF receptors in mammalian development and congenital diseases. Birth Defects Res. Part C. Embryo Today 69 (2003) 286-304
62. Ventura A., Meissner A., Dillon C.P., McManus M., Sharp P.A., Van Parijs L., et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101 (2004) 10380-10385
63. Branda C.S., and Dymecki S.M. Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev. Cell. 6 (2004) 7-28
64. Coumoul X., Shukla V., Li C., Wang R.H., and Deng C.X. Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. Nucleic Acids Res. 33 (2005) e102
65. Chang H.S., Lin C.H., Chen Y.C., and Yu W.C. Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. Am. J. Pathol. 165 (2004) 1535-1541
66. Behlke M.A. Progress towards in vivo use of siRNAs. Mol. Ther. 13 (2006) 644-670
67. Kim D.H., and Rossi J.J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8 (2007) 173-184